Glucagon-like peptide-1 (GLP-1) receptor agonistsincluding semaglutide (Ozempic, Wegovy), liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), and tirzepatide (Mounjaro, Zepbound)are FDA-approved medications for type 2 diabetes and chronic weight management
Salt and Crystal Engineering The clinical candidate uses the optimized TRIS salt Form A monohydrate (WO2024217553A1, CAS: 3059756-05-4)
Mechanistically, these effects are linked to GLP-1 RA-mediated suppression of inflammatory pathways, modulation of skeletal muscle metabolism, and preservation of mitochondrial function, thereby influencing insulin resistance
This dual mechanism tends to produce stronger appetite suppression and, in some cases, more pronounced GI side effects during dose escalation
For example, if you go grocery shopping once a week or have a weekly yoga class you attend, it may be helpful to take your Ozempic shot before or after you go
The most persistent misconception: I lost the weight, so I can stop. Discontinuation typically leads to regain of roughly two-thirds of lost weight over time
